CareLit Fachartikel

Riociguat for pulmonary hypertension – experience from a referral center

H Gall, MJ Richter, K Tello, J Grimminger, F Grimminger, W Seeger, A Ghofrani · Pneumologie · 2016 · Heft 02

Dokument
987594
CareLit-ID
Jahr
2016
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Pneumologie
Autor:innen
H Gall, MJ Richter, K Tello, J Grimminger, F Grimminger, W Seeger, A Ghofrani
Ausgabe
Heft 02 / 2016
Seiten
–
Erschienen: 2016-02-09 00:00:00
ISSN
0934-8387
DOI
10.1055/s-0036-1572023

Zusammenfassung

Background: Several achievements have been made in the treatment of pulmonary hypertension (PH). Soluble guanylate cyclase (sGC) stimulator Riociguat has been approved for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) and is available in Europe since April 2014. Methods: A one-year prospective data collection of PH patients that started oral targeted therapy after right heart catheterization (RHC) at our center from April 2014. Parameters of treatment efficacy were prospectively assessed. Results: 56 PAH and 49 CTEPH patients had a RHC before ini…

Schlagworte

Pneumologie